SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-052593
Filing Date
2020-11-09
Accepted
2020-11-09 17:13:23
Documents
70
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cogt-10q_20200930.htm 10-Q 2529353
2 EX-10.5 cogt-ex105_462.htm EX-10.5 505887
3 EX-10.7 cogt-ex107_461.htm EX-10.7 112033
4 EX-31.1 cogt-ex311_6.htm EX-31.1 9995
5 EX-31.2 cogt-ex312_7.htm EX-31.2 9953
6 EX-32.1 cogt-ex321_9.htm EX-32.1 5983
7 EX-32.2 cogt-ex322_8.htm EX-32.2 5928
  Complete submission text file 0001564590-20-052593.txt   7551229

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT cogt-20200930.xml EX-101.INS 992278
9 XBRL TAXONOMY EXTENSION SCHEMA cogt-20200930.xsd EX-101.SCH 57914
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cogt-20200930_cal.xml EX-101.CAL 48364
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cogt-20200930_def.xml EX-101.DEF 231772
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE cogt-20200930_lab.xml EX-101.LAB 433418
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cogt-20200930_pre.xml EX-101.PRE 356647
Mailing Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140
Business Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140 617-945-5576
Cogent Biosciences, Inc. (Filer) CIK: 0001622229 (see all company filings)

IRS No.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38443 | Film No.: 201298714
SIC: 2834 Pharmaceutical Preparations